Royce & Associates LP Sells Stake in Transcat, Inc.

Institutional investor reduces holdings in scientific instruments company

Mar. 2, 2026 at 4:07pm

Royce & Associates LP, an institutional investor, has reduced its stake in Transcat, Inc. (NASDAQ:TRNS) by 13.5% in the third quarter, according to a recent SEC filing. The firm now owns 338,772 shares of the scientific and technical instruments company's stock, down from 391,779 shares previously.

Why it matters

Transcat is a leading provider of calibration, laboratory, and metrology services in North America, specializing in ensuring the accuracy and compliance of measurement instruments across various industries. The reduction in Royce & Associates' stake could signal a shift in investor sentiment or portfolio rebalancing, which may impact the stock price and market perception of the company.

The details

According to the SEC filing, Royce & Associates LP sold 53,007 shares of Transcat, reducing its ownership to approximately 3.63% of the company's outstanding shares. The institutional investor cited unspecified reasons for the stake reduction, which occurred during the third quarter of the company's fiscal year.

  • Royce & Associates LP reduced its stake in Transcat, Inc. in the 3rd quarter of the company's fiscal year.

The players

Royce & Associates LP

An institutional investor that has reduced its stake in Transcat, Inc.

Transcat, Inc.

A leading provider of calibration, laboratory, and metrology services in North America, specializing in ensuring the accuracy and compliance of measurement instruments across various industries.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Royce & Associates' stake in Transcat, Inc. could signal a shift in investor sentiment or portfolio rebalancing, which may impact the stock price and market perception of the company. As a leading provider of specialized services, Transcat's performance and market position will continue to be closely watched by investors and industry analysts.